EUVIMEDEUVIMED entdecken
Open Access

Treatment outcomes in current smokers versus former smokers undergoing concurrent chemoradiotherapy for head and neck cancer

Samreen Zaheer, Aditi Agrawal, Arshida P, Mohammad Akram

The Indian Journal of Medical Research · 04.04.2026 · 163 · 415-419

DOI: 10.25259/ijmr_1931_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 04.04.2026. Verfasst von Samreen Zaheer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University, Aligarh, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Chemoradiotherapy, Head and Neck Neoplasms, Smoking. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Head and neck cancers are aggressive tumours with a multidisciplinary treatment strategy. Concurrent chemoradiotherapy is recommended for locally advanced cases. The carboxyhaemoglobin level is higher in smokers, resulting in a hypoxic environment and radio resistance, which affect treatment outcomes. Data for effect of continued smoking is not available in the Indian setting. This study aims to compare treatment response, failure rate, patterns, and progression-free survival in current smokers vs. former smokers receiving definitive concurrent chemoradiotherapy for head and neck cancer.

Methods

We conducted this retrospective observational study in patients receiving definitive chemoradiotherapy for head and neck cancer with two groups: current smokers and former smokers. Both arms received weekly 40 mg/m 2 cisplatin along with radiotherapy. Endpoints included treatment response, progression-free survival, and failure patterns.

Results

There were fewer complete treatment responses and more failures in current smokers receiving CRT, with a significant difference in progression-free survival. Interpretation & conclusions Continued smoking during definitive chemoradiotherapy for head and neck cancers resulted in poorer treatment outcomes. Integrating tobacco cessation in oncological care should be a standard of care in managing head and neck cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChemoradiotherapyHead and Neck NeoplasmsSmokingHumansMaleFemaleMiddle AgedTreatment OutcomeCisplatinSmokersAgedAdultRetrospective StudiesProgression-Free Survival

Stichwörter der Autor:innen

Current smokersDefinitive concurrent chemoradiotherapyHead and neck cancerProgression-free survivalTreatment outcomes

Substanzen

Cisplatin

Autor:innen und Institutionen

  • Department of Radiotherapy, Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Zitieren

APA

Zaheer, S., Agrawal, A., P, A., & Akram, M. (2026). Treatment outcomes in current smokers versus former smokers undergoing concurrent chemoradiotherapy for head and neck cancer. The Indian Journal of Medical Research, 163, 415-419. https://doi.org/10.25259/ijmr_1931_2025

Vancouver

Zaheer S, Agrawal A, P A, Akram M. Treatment outcomes in current smokers versus former smokers undergoing concurrent chemoradiotherapy for head and neck cancer. The Indian Journal of Medical Research. 2026;163:415-419. doi:10.25259/ijmr_1931_2025

BibTeX
@article{Zaheer2026,
  author = {Zaheer, Samreen and Agrawal, Aditi and P, Arshida and Akram, Mohammad},
  title = {Treatment outcomes in current smokers versus former smokers undergoing concurrent chemoradiotherapy for head and neck cancer},
  journal = {The Indian Journal of Medical Research},
  year = {2026},
  volume = {163},
  pages = {415--419},
  doi = {10.25259/ijmr_1931_2025}
}
Kostenlos starten →